View Financial HealthPerk Labs 배당 및 자사주 매입배당 기준 점검 0/6Perk Labs 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jun 14Perk Labs Inc. announced that it expects to receive CAD 2.5 million in fundingPerk Labs Inc. announced a non-brokered private placements of units and convertible debentures on June 12, 2024. The Company is proposing a new non-brokered private placement of up to 115,384,615 units at a price of CAD 0.013 per Unit for gross proceeds of up to CAD 1,499,999.995 and convertible debentures for gross proceeds of up to CAD 1,000,000; aggregate gross proceeds of CAD 2,499,999.995. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the Closing. The convertible debentures will be offered for a 2-year term at an interest rate of 15% and will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share. The private placements of the Units and the convertible debentures are expected to close on or before June 29, 2024. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placements will be subject to a statutory hold period of four months and one day following the Closing. A finder’s fee may be payable in connection with the Private Placements.공시 • Apr 26Perk Labs Inc. announced that it has received CAD 1.714 million in fundingOn April 25, 2024, Perk Labs Inc. closed the transaction. The company announced that it has issued 78,900,000 units at a price of CAD 0.01 per unit for the gross proceeds of CAD 789,000 and 15% convertible debentures for the gross proceeds of CAD 25,000; aggregate gross proceeds of CAD 814,000 in third and final tranche. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature two years from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share, subject to the terms and conditions set forth in the specific Debenture agreement. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. In connection with private placements, B. Rogic acquired CAD 73,000 of Units공시 • Dec 14+ 1 more updatePerk Labs Inc. Announces Issuance of U.S. PatentPerk Labs Inc. announced the issuance of its United States patent that protects the Company's rights to one of its inventions for systems and methods for electronic payments with fraud prevention, based on correlating transaction data and information from a user's device.공시 • Sep 29Perk Labs Inc. announced that it has received CAD 0.471 million in fundingOn September 28, 2023, Perk Labs Inc. closed the transaction. The company issued 1,312,500 units at an issue price of CAD 0.016 per unit for the gross proceeds of CAD 21,000 and convertible debentures for the gross proceeds of CAD 450,000; aggregate gross proceeds of CAD 471,000. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature one year from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. The bonds will mature on September 28, 2024.공시 • Jul 15+ 1 more updatePerk Labs Inc. announced that it expects to receive CAD 0.35 million in fundingPerk Labs Inc. announced a non-brokered private placement of 6,250,000 units at an issue price of CAD 0.016 per unit for the gross proceeds of up to CAD 100,000 and convertible debentures for the gross proceeds of CAD 250,000, for the aggregate gross proceeds of CAD 350,000 on July 14, 2023. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per common share for a period of 24 months from the Closing. The convertible debentures will be offered on varying terms, including interest rates ranging from 5% to 15% and differing acceleration terms and maturity dates specific to the terms of each convertible debenture agreement. The convertible debentures will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share, subject to the terms and conditions set forth in the specific convertible debenture agreement. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placement will be subject to a statutory hold period of four months and one day following the Closing. The private placement of the Units and the convertible debentures is expected to close on or before August 24, 2023.공시 • Jul 10Perk Labs Inc. Announces Patrick Power Resigns from BoardPerk Labs Inc. at its Annual General Meeting of Shareholders held on July 5, 2023, announced Patrick Power has submitted his resignation to the Board. After review and consideration, the Board has accepted Mr. Power's resignation.공시 • May 25Perk Labs Inc., Annual General Meeting, Jul 05, 2023Perk Labs Inc., Annual General Meeting, Jul 05, 2023.공시 • Jan 21Perk Labs Inc. Announces CFO TransitionPerk Labs Inc. announced that effective February 17, 2023, Andrew Bailes, a seasoned finance executive, will succeed Ms. Altamirano as Interim CFO until a permanent CFO is named. Vanessa Altamirano will step down effective February 17, 2023 to pursue another professional opportunity. Perk is currently in the process of structuring a merger with Getit Technologies Inc. (‘Getit’), and as part of the process, the Company continues to review its team to optimise the integration of the two companies. Andrew Bailes is a Chartered Public Accountant, Principal at Hertford Advisors and has served in CFO roles since 2006. He has extensive experience in IT, Telecoms, Logistics, manufacturing and other sectors, managing finance and Legal, HR and Operational functions. Andrew did his undergraduate degree in Mathematics and Management Studies at Cambridge University in the UK and was top in his Executive MBA at Cornell and Queens. His notable achievements include: CFO for various capital raises totaling over $100 million Negotiation of many multi-million dollar debt facilities Head of a 25-man Finance Department at one of Ottawa's larger production facilities Twenty-five years' experience in Business and Strategic planning .공시 • Jan 05Perk Labs Inc. Appoints Patrick Power to the Board of DirectorsPerk Labs Inc. announced that it has appointed Mr. Patrick Power to the company's board of directors, effective immediately. Mr. Power brings a wealth of experience in business and finance to the board. He is the Chairman and President of James Edward Capital Corporation, an Ottawa-based boutique investment bank focused on emerging growth companies and is advising the Company on its strategic options. Mr. Power has significant experience in finance and governance, having previously served in senior executive roles for several TSX/TSXV-listed technology companies.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 PKLB.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: PKLB.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Perk Labs 배당 수익률 vs 시장PKLB.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (PKLB.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Software)0.9%분석가 예측 (PKLB.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 PKLB.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 PKLB.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 PKLB.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: PKLB.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/19 16:36종가2026/05/12 00:00수익2023/08/31연간 수익2022/11/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Perk Labs Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jun 14Perk Labs Inc. announced that it expects to receive CAD 2.5 million in fundingPerk Labs Inc. announced a non-brokered private placements of units and convertible debentures on June 12, 2024. The Company is proposing a new non-brokered private placement of up to 115,384,615 units at a price of CAD 0.013 per Unit for gross proceeds of up to CAD 1,499,999.995 and convertible debentures for gross proceeds of up to CAD 1,000,000; aggregate gross proceeds of CAD 2,499,999.995. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the Closing. The convertible debentures will be offered for a 2-year term at an interest rate of 15% and will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share. The private placements of the Units and the convertible debentures are expected to close on or before June 29, 2024. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placements will be subject to a statutory hold period of four months and one day following the Closing. A finder’s fee may be payable in connection with the Private Placements.
공시 • Apr 26Perk Labs Inc. announced that it has received CAD 1.714 million in fundingOn April 25, 2024, Perk Labs Inc. closed the transaction. The company announced that it has issued 78,900,000 units at a price of CAD 0.01 per unit for the gross proceeds of CAD 789,000 and 15% convertible debentures for the gross proceeds of CAD 25,000; aggregate gross proceeds of CAD 814,000 in third and final tranche. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature two years from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share, subject to the terms and conditions set forth in the specific Debenture agreement. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. In connection with private placements, B. Rogic acquired CAD 73,000 of Units
공시 • Dec 14+ 1 more updatePerk Labs Inc. Announces Issuance of U.S. PatentPerk Labs Inc. announced the issuance of its United States patent that protects the Company's rights to one of its inventions for systems and methods for electronic payments with fraud prevention, based on correlating transaction data and information from a user's device.
공시 • Sep 29Perk Labs Inc. announced that it has received CAD 0.471 million in fundingOn September 28, 2023, Perk Labs Inc. closed the transaction. The company issued 1,312,500 units at an issue price of CAD 0.016 per unit for the gross proceeds of CAD 21,000 and convertible debentures for the gross proceeds of CAD 450,000; aggregate gross proceeds of CAD 471,000. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature one year from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. The bonds will mature on September 28, 2024.
공시 • Jul 15+ 1 more updatePerk Labs Inc. announced that it expects to receive CAD 0.35 million in fundingPerk Labs Inc. announced a non-brokered private placement of 6,250,000 units at an issue price of CAD 0.016 per unit for the gross proceeds of up to CAD 100,000 and convertible debentures for the gross proceeds of CAD 250,000, for the aggregate gross proceeds of CAD 350,000 on July 14, 2023. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per common share for a period of 24 months from the Closing. The convertible debentures will be offered on varying terms, including interest rates ranging from 5% to 15% and differing acceleration terms and maturity dates specific to the terms of each convertible debenture agreement. The convertible debentures will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share, subject to the terms and conditions set forth in the specific convertible debenture agreement. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placement will be subject to a statutory hold period of four months and one day following the Closing. The private placement of the Units and the convertible debentures is expected to close on or before August 24, 2023.
공시 • Jul 10Perk Labs Inc. Announces Patrick Power Resigns from BoardPerk Labs Inc. at its Annual General Meeting of Shareholders held on July 5, 2023, announced Patrick Power has submitted his resignation to the Board. After review and consideration, the Board has accepted Mr. Power's resignation.
공시 • May 25Perk Labs Inc., Annual General Meeting, Jul 05, 2023Perk Labs Inc., Annual General Meeting, Jul 05, 2023.
공시 • Jan 21Perk Labs Inc. Announces CFO TransitionPerk Labs Inc. announced that effective February 17, 2023, Andrew Bailes, a seasoned finance executive, will succeed Ms. Altamirano as Interim CFO until a permanent CFO is named. Vanessa Altamirano will step down effective February 17, 2023 to pursue another professional opportunity. Perk is currently in the process of structuring a merger with Getit Technologies Inc. (‘Getit’), and as part of the process, the Company continues to review its team to optimise the integration of the two companies. Andrew Bailes is a Chartered Public Accountant, Principal at Hertford Advisors and has served in CFO roles since 2006. He has extensive experience in IT, Telecoms, Logistics, manufacturing and other sectors, managing finance and Legal, HR and Operational functions. Andrew did his undergraduate degree in Mathematics and Management Studies at Cambridge University in the UK and was top in his Executive MBA at Cornell and Queens. His notable achievements include: CFO for various capital raises totaling over $100 million Negotiation of many multi-million dollar debt facilities Head of a 25-man Finance Department at one of Ottawa's larger production facilities Twenty-five years' experience in Business and Strategic planning .
공시 • Jan 05Perk Labs Inc. Appoints Patrick Power to the Board of DirectorsPerk Labs Inc. announced that it has appointed Mr. Patrick Power to the company's board of directors, effective immediately. Mr. Power brings a wealth of experience in business and finance to the board. He is the Chairman and President of James Edward Capital Corporation, an Ottawa-based boutique investment bank focused on emerging growth companies and is advising the Company on its strategic options. Mr. Power has significant experience in finance and governance, having previously served in senior executive roles for several TSX/TSXV-listed technology companies.